Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rayner

Showing results (151-160 of 422) with videos related to

Pageof 43
Sort By:
Diabetologia|August 13, 2017
Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathyChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
Neurogastroenterology and Motility|May 17, 2006
'Gastric' hypoglycaemia--an important concept in diabetes managementM Horowitz, K L Jones, C K Rayner, et al.
Journal of Experimental Psychology. Learning, Memory, and Cognition|July 1, 1988
Elaborative inferences during reading: do they occur on-line?E J O'Brien, D M Shank, J L Myers, et al.
Peptides|March 26, 2013
Glucagon-like peptides 1 and 2 in health and disease: a reviewChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
Diabetes, Obesity & Metabolism|October 27, 2017
Targeting postprandial glycaemia in children with diabetes: Opportunities and challengesMyfanwy C Geyer, Christopher K Rayner, Michael Horowitz, et al.
World Journal of Diabetes|August 5, 2024
Management of gestational diabetes mellitus <i>via</i> nutritional interventions: The relevance of gastric emptyingWei-Kun Huang, Ryan J Jalleh, Christopher K Rayner, et al.
The Journal of Clinical Endocrinology and Metabolism|June 5, 2020
Effects of Proximal and Distal Enteral Glucose Infusion on Cardiovascular Response in Health and Type 2 DiabetesXiang Zhang, Karen L Jones, Michael Horowitz, et al.
Diabetes, Obesity & Metabolism|January 7, 2017
Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: Incidence and consequencesMichael Horowitz, Vanita R Aroda, Jenny Han, et al.
Autonomic Neuroscience : Basic & Clinical|September 11, 2020
Gastrointestinal autonomic neuropathy in diabetesChinmay S Marathe, Karen L Jones, Tongzhi Wu, et al.
Diabetes Care|October 21, 2021
Comment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial. Diabetes Care 2020;43:2509-2518Chinmay S Marathe, Karen L Jones, Christopher K Rayner, et al.
Pageof 43

Showing results (151-160 of 422) with videos related to

Sort By:
Pageof 43
Diabetologia|August 13, 2017
Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathyChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
Neurogastroenterology and Motility|May 17, 2006
'Gastric' hypoglycaemia--an important concept in diabetes managementM Horowitz, K L Jones, C K Rayner, et al.
Journal of Experimental Psychology. Learning, Memory, and Cognition|July 1, 1988
Elaborative inferences during reading: do they occur on-line?E J O'Brien, D M Shank, J L Myers, et al.
Peptides|March 26, 2013
Glucagon-like peptides 1 and 2 in health and disease: a reviewChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.
Diabetes, Obesity & Metabolism|October 27, 2017
Targeting postprandial glycaemia in children with diabetes: Opportunities and challengesMyfanwy C Geyer, Christopher K Rayner, Michael Horowitz, et al.
World Journal of Diabetes|August 5, 2024
Management of gestational diabetes mellitus <i>via</i> nutritional interventions: The relevance of gastric emptyingWei-Kun Huang, Ryan J Jalleh, Christopher K Rayner, et al.
The Journal of Clinical Endocrinology and Metabolism|June 5, 2020
Effects of Proximal and Distal Enteral Glucose Infusion on Cardiovascular Response in Health and Type 2 DiabetesXiang Zhang, Karen L Jones, Michael Horowitz, et al.
Diabetes, Obesity & Metabolism|January 7, 2017
Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: Incidence and consequencesMichael Horowitz, Vanita R Aroda, Jenny Han, et al.
Autonomic Neuroscience : Basic & Clinical|September 11, 2020
Gastrointestinal autonomic neuropathy in diabetesChinmay S Marathe, Karen L Jones, Tongzhi Wu, et al.
Diabetes Care|October 21, 2021
Comment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial. Diabetes Care 2020;43:2509-2518Chinmay S Marathe, Karen L Jones, Christopher K Rayner, et al.
Pageof 43